logo
搜索
菜单

Bioavailab的搜索结果

当前1/1页
排序: 最近更新
17.7: Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein 01:20 min
17.7: Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
3.29: Prodrugs 01:30 min
3.29: Prodrugs
3.8: First Pass Effect 01:12 min
3.8: First Pass Effect
1.9: Routes of Drug Administration: Overview 01:22 min
1.9: Routes of Drug Administration: Overview
6.7: Adrenergic Agonists: Mixed-Action Agents 01:28 min
6.7: Adrenergic Agonists: Mixed-Action Agents
3.27: Rational Dosage Regimen: Maintenance Dose and Loading Dose 01:24 min
3.27: Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.7: Bioequivalence: Overview 01:16 min
3.7: Bioequivalence: Overview
3.6: Factors Influencing Bioavailability: First-Pass Elimination 01:23 min
3.6: Factors Influencing Bioavailability: First-Pass Elimination
3.5: Bioavailability: Overview 01:13 min
3.5: Bioavailability: Overview
1.11: Routes of Drug Administration: Parenteral 01:25 min
1.11: Routes of Drug Administration: Parenteral
1.4: Drug Nomenclature 01:17 min
1.4: Drug Nomenclature
12.6: Crossover Experiments 01:16 min
12.6: Crossover Experiments
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs 10.3791/2460-v
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
5.6: Compound Administration I 15:06 min
5.6: Compound Administration I
返回顶部